This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heartattack 2. I'm Interested In Case You Missed Them: 1 Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases. 2021 , 22 , 5770. 2021 Jul 17;398(10296):238-248.
In general, the more calcified or fibrous a plaque is, the less dangerous it is, as it is less likely to rupture and cause a heartattack. Fatty or necrotic plaque is often described as ‘vulnerable’ plaque, with the vulnerability being related to the risk of a heartattack. Sci Rep 11 , 7999 (2021).
Everyone should have an Lp(a) blood test at least once, but this is an absolutely must-do test if you have an early family history of heartdisease. However, that does not mean you cannot reduce the overall risk of early heartdisease. 2021 Aug 3;78(5):421-433. 2021 Aug 3;78(5):421-433. J Am Coll Cardiol.
Preventing or delaying the onset of coronary artery disease is a great strategy for living longer. The challenge is that the things you do to prevent heartdisease are unlikely to pay dividends for a very long time—many years if not decades. This is a program that starts the day of your heartattack.
. ‘ Snipers Alley ’, it turns out, is an age between 40-60, where mostly males were having fatal heartattacks. These patients were not overly bothered about having a heartattack at age 80, but usually, one of their friends, aged 52 or so, had just had a heartattack, and they did not want to be next.
Not just for the prevention of heartdisease but also to reduce your risk of dying from all conditions. For every 20mmHg increase in systolic (Top Number) blood pressure, the risk of dying from a heartattack or stroke doubles 3. If you have a family history of heartdisease, this is a must-do test.
Preventing heartdisease is possible. To prevent heartdisease, you need to know what causes it, how to measure the relevant factors and what to do about them. When we say heartdisease, what we really mean is plaque in the artery wall. No heartattacks. 2021 Mar 23;77(11):1439-1450.
If you have an early family history of heartdisease, there are specific steps you need to take to define if you have an increased risk and what to do about it. Heartdisease is the leading cause of death worldwide, and the probability of someone in your family having heartdisease is likely to be high.
Meanwhile, traditional methods for cardiac detection still rely on reactive, symptom-driven interventions that often catch heartdisease too late, when treatment is complex, critical and costly. AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions.
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
Researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heartattacks and vascular death among stroke survivors three months after a stroke. In 2021, there were 7.44
with SmartAssist ; Impella LD Product Codes: See Recall Database Entry Distribution Dates: October 10, 2021 to October 10, 2023 Devices Recalled in the U.S.: Impella therapy aims to reduce the work of the heart's ventricles and provide support for the circulatory system so the heart has time to recover.
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heartattack, stroke and death for people with Peripheral Artery Disease (PAD).
A higher daily step count is also linked to significantly lower cancer, stroke and heartdisease rates. Daily step counts of over 16,000 steps have been linked to over a 50% reduction in the rates of heartattacks 2. 2021 Sep 1;4(9):e2124516. JAMA Netw Open. J Am Coll Cardiol. null2023, 0 (0).
Calcified plaques are known to be more stable and less prone to rupture and lead to a heartattack. In other words, even though athletes may have more plaque, the plaque composition may be more benign and thus, not be associated with a greater cardiovascular disease risk.
They include coronary artery disease, cerebrovascular disease, and rheumatic heartdisease. More than four in five cardiovascular deaths are caused by heartattacks and strokes, and a third of these deaths occur in people under the age of 70. They accounted for about 35% of all deaths in 2021.
Getty Images milla1cf Mon, 04/29/2024 - 13:06 April 29, 2024 — Women with heartdisease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024 , a scientific congress of the European Society of Cardiology ( ESC ).1 Eur Heart J. Eur J Prev Cardiol.
Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heartattack, or stroke in adults with known heartdisease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.
He has authored books including “ The Great Cholesterol Con ” (2008), “ Doctoring Data ” (2015), “ A Statin Nation: Damaging Millions in a Brave New Post-Health World ” (2018) and “ The Clot Thickens: The enduring mystery of heartdisease ” (2021). IN THE HIGH COURT OF JUSTICE Claim Nos.
30th October 2022 [How fewer doctors means more doctors – it’s official] This blog has nothing to do with heartdisease, or vaccines, or anything directly about medical practice at all. However, it does have a great deal to do with data manipulation, which is something very close to my heart. Even GP numbers have increased!
This misinformation would have resulted in many thousands of people giving up their medication and suffering heartattacks and strokes as a result. Why do these attacks happen? And if you dare to suggest the idea that low-fat foods do not protect against heartdisease, you get much the same treatment.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content